Danaher EBITDA Margin 2010-2024 | DHR
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Danaher (DHR) over the last 10 years. The current EBITDA margin for Danaher as of March 31, 2024 is .
| Danaher EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2024-03-31 |
$23.74B |
$7.25B |
30.53% |
| 2023-12-31 |
$23.89B |
$7.38B |
30.87% |
| 2023-09-30 |
$23.52B |
$7.68B |
32.64% |
| 2023-06-30 |
$24.31B |
$8.24B |
33.89% |
| 2023-03-31 |
$24.90B |
$8.98B |
36.07% |
| 2022-12-31 |
$26.64B |
$9.67B |
36.29% |
| 2022-09-30 |
$26.60B |
$9.61B |
36.13% |
| 2022-06-30 |
$26.17B |
$8.93B |
34.14% |
| 2022-03-31 |
$25.63B |
$8.71B |
33.97% |
| 2021-12-31 |
$24.80B |
$8.50B |
34.26% |
| 2021-09-30 |
$28.07B |
$9.09B |
32.38% |
| 2021-06-30 |
$26.72B |
$9.01B |
33.71% |
| 2021-03-31 |
$24.80B |
$8.00B |
32.24% |
| 2020-12-31 |
$22.28B |
$6.46B |
29.00% |
| 2020-09-30 |
$20.39B |
$5.58B |
27.34% |
| 2020-06-30 |
$18.89B |
$4.85B |
25.66% |
| 2020-03-31 |
$18.03B |
$4.44B |
24.61% |
| 2019-12-31 |
$17.91B |
$4.46B |
24.90% |
| 2019-09-30 |
$15.56B |
$4.01B |
25.79% |
| 2019-06-30 |
$16.04B |
$4.09B |
25.52% |
| 2019-03-31 |
$16.57B |
$4.19B |
25.25% |
| 2018-12-31 |
$17.05B |
$4.23B |
24.83% |
| 2018-09-30 |
$16.80B |
$4.13B |
24.60% |
| 2018-06-30 |
$16.48B |
$4.05B |
24.59% |
| 2018-03-31 |
$16.01B |
$3.83B |
23.93% |
| 2017-12-31 |
$15.52B |
$3.69B |
23.78% |
| 2017-09-30 |
$17.83B |
$3.99B |
22.40% |
| 2017-06-30 |
$17.43B |
$3.90B |
22.36% |
| 2017-03-31 |
$17.16B |
$3.91B |
22.76% |
| 2016-12-31 |
$16.88B |
$3.86B |
22.89% |
| 2016-09-30 |
$13.57B |
$3.11B |
22.93% |
| 2016-06-30 |
$12.95B |
$2.75B |
21.24% |
| 2016-03-31 |
$13.66B |
$2.93B |
21.47% |
| 2015-12-31 |
$14.43B |
$3.04B |
21.08% |
| 2015-09-30 |
$18.58B |
$3.72B |
20.01% |
| 2015-06-30 |
$19.78B |
$4.17B |
21.10% |
| 2015-03-31 |
$19.78B |
$4.13B |
20.87% |
| 2014-12-31 |
$19.75B |
$4.15B |
21.02% |
| 2014-09-30 |
$19.60B |
$4.29B |
21.87% |
| 2014-06-30 |
$19.56B |
$4.25B |
21.75% |
| 2014-03-31 |
$19.34B |
$4.19B |
21.68% |
| 2013-12-31 |
$19.12B |
$4.13B |
21.58% |
| 2013-09-30 |
$18.83B |
$4.13B |
21.95% |
| 2013-06-30 |
$18.57B |
$4.06B |
21.86% |
| 2013-03-31 |
$18.39B |
$4.02B |
21.84% |
| 2012-12-31 |
$18.26B |
$4.01B |
21.93% |
| 2012-09-30 |
$18.00B |
$3.91B |
21.69% |
| 2012-06-30 |
$18.03B |
$3.79B |
21.02% |
| 2012-03-31 |
$17.12B |
$3.50B |
20.45% |
| 2011-12-31 |
$16.09B |
$3.25B |
20.21% |
| 2011-09-30 |
$14.61B |
$2.93B |
20.05% |
| 2011-06-30 |
$13.25B |
$2.73B |
20.57% |
| 2011-03-31 |
$12.83B |
$2.61B |
20.35% |
| 2010-12-31 |
$12.55B |
$2.44B |
19.43% |
| 2010-09-30 |
$11.78B |
$2.15B |
18.24% |
| 2010-06-30 |
$11.44B |
$2.05B |
17.92% |
| 2010-03-31 |
$10.90B |
$1.87B |
17.11% |
| 2009-12-31 |
$10.52B |
$1.77B |
16.84% |
| Sector |
Industry |
Market Cap |
Revenue |
| Multi-Sector Conglomerates |
Diversified Operations |
$182.061B |
$23.890B |
|
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
|
